Bio-Techne Corporation (TECH)
NASDAQ: TECH · Real-Time Price · USD
73.17
+1.78 (2.49%)
Dec 20, 2024, 4:00 PM EST - Market closed
Bio-Techne Revenue
Bio-Techne had revenue of $289.46M in the quarter ending September 30, 2024, with 4.52% growth. This brings the company's revenue in the last twelve months to $1.17B, up 2.41% year-over-year. In the fiscal year ending June 30, 2024, Bio-Techne had annual revenue of $1.16B with 1.97% growth.
Revenue (ttm)
$1.17B
Revenue Growth
+2.41%
P/S Ratio
9.86
Revenue / Employee
$384,126
Employees
3,050
Market Cap
11.63B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Jun 30, 2024 | 1.16B | 22.36M | 1.97% |
Jun 30, 2023 | 1.14B | 31.10M | 2.81% |
Jun 30, 2022 | 1.11B | 174.57M | 18.75% |
Jun 30, 2021 | 931.03M | 192.34M | 26.04% |
Jun 30, 2020 | 738.69M | 24.69M | 3.46% |
Jun 30, 2019 | Pro | Pro | Pro |
Jun 30, 2018 | Pro | Pro | Pro |
Jun 30, 2017 | Pro | Pro | Pro |
Jun 30, 2016 | Pro | Pro | Pro |
Jun 30, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Tenet Healthcare | 20.97B |
Universal Health Services | 15.42B |
DaVita | 12.67B |
Solventum | 8.22B |
BioMarin Pharmaceutical | 2.75B |
Exact Sciences | 2.69B |
Globus Medical | 2.48B |
Sarepta Therapeutics | 1.64B |
TECH News
- 1 day ago - BIO-TECHNE TO PRESENT AT THE 43rd ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE - PRNewsWire
- 2 days ago - BIO-TECHNE ANNOUNCES BIOTHERAPEUTIC CHARACTERIZATION STRATEGIC CO-MARKETING AND CO-PROMOTION AGREEMENT - PRNewsWire
- 3 days ago - ScaleReady awards a G-Rex® Grant to Moonlight Bio - PRNewsWire
- 9 days ago - BIO-TECHNE ANNOUNCES NEW DISTRIBUTION AGREEMENT WITH MEDSANTEK TO EXPAND ACCESS TO PORTFOLIO ACROSS TURKEY - PRNewsWire
- 11 days ago - BIO-TECHNE LAUNCHES ESR1 MUTATION MONITORING ASSAY - PRNewsWire
- 24 days ago - BIO-TECHNE TO PRESENT AT THE CITI 2024 GLOBAL HEALTHCARE CONFERENCE - PRNewsWire
- 26 days ago - Gemini Bioproducts, LLC Acquires Selected Fetal Bovine Serum (FBS) Product Rights and Inventory from Bio-Techne - PRNewsWire
- 4 weeks ago - OverT Bio Receives $120K G-Rex® Grant to Propel Solid Tumor Cell Therapy Advancements - Business Wire